公开(公告)号：US20080033003A1

公开(公告)日：2008-02-07

申请号：US11596015

申请日：2005-05-04

申请人： Claudio Pisano ,  Giuseppe Giannini ,  Maria Omella Tinti ,  Loredana Vesci ,  Domenico Alloatti ,  Sergio Penco ,  Alma Dal Pozzo ,  Ni Minghong ,  Sabrina Dallavalle ,  Lucio Merlini ,  Franco Zunino

发明人： Claudio Pisano ,  Giuseppe Giannini ,  Maria Omella Tinti ,  Loredana Vesci ,  Domenico Alloatti ,  Sergio Penco ,  Alma Dal Pozzo ,  Ni Minghong ,  Sabrina Dallavalle ,  Lucio Merlini ,  Franco Zunino

IPC分类号： A61K31/436 ,  A61P31/12 ,  A61P33/00 ,  A61P35/00 ,  A61P35/04

CPC分类号： C07K7/52 ,  A61K38/00

摘要： Compounds of Formula (I) are described in which the R1 group is as defined in the specification and includes the condensation of the camptothecin molecule in position 7 with a cyclopeptide containing the RGD sequence. Said compounds are endowed both with high affinity for integrin receptors αvβ3 and αvβ5 and with selective cytotoxic activity on human tumour cell lines at micromolar concentrations.

摘要翻译： 描述了式（I）的化合物，其中R 1 H 1基团如说明书中所定义，并且包括位置7上的喜树碱分子与含有RGD序列的环肽的缩合。 所述化合物赋予对整联蛋白受体α和β5β5的高亲和力，并与 在微摩尔浓度下对人肿瘤细胞系的选择性细胞毒活性。

公开(公告)号：US20070043067A1

公开(公告)日：2007-02-22

申请号：US10564637

申请日：2004-07-06

申请人： Giuseppe Giannini ,  Claudio Pisano ,  Loredana Vesci ,  Maria Omella Tinti ,  Lucio Merlini ,  Sergio Penco ,  Franco Zunino

发明人： Giuseppe Giannini ,  Claudio Pisano ,  Loredana Vesci ,  Maria Omella Tinti ,  Lucio Merlini ,  Sergio Penco ,  Franco Zunino

IPC分类号： A61K31/4745 ,  C07D491/14

CPC分类号： C07D491/22 ,  Y02P20/55

摘要： Compounds are disclosed with the general formula in which the groups are as defined in the description here below and characterized by the presence of polyamine substituents on the imine/oxime residue, such amine groups being in turn protected by suitable protective groups. Said compounds are endowed with potent topoisomerase I inhibiting activity and therefore are useful as medicaments for the treatment of tumours and viral and parasite infections.

摘要翻译： 公开了具有通式的化合物，其中基团如下文描述中所定义，并且其特征在于亚胺/肟残基上存在多胺取代基，此类胺基又被合适的保护基保护。 所述化合物具有有效的拓扑异构酶I抑制活性，因此可用作治疗肿瘤和病毒和寄生虫感染的药物。